Breakthrough in Sleep Apnea Management
The FDA has marked a historic milestone by approving the first pharmaceutical treatment option for certain patients with obstructive sleep apnea. Dr. Sally Seymour, director of the FDA’s division of…
Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA carries profound health and quality-of-life…
Continue Reading
On Thursday, a Belgian sleep diagnostics company named Sunrise announced plans to begin delivering sleep care in the U.S. through the acquisition of Dreem Health, a California-based sleep clinic.
Sunrise was founded in 2015 to…
Continue Reading
What You Should Know:
– Researchers at Stanford University, in collaboration with SoundHealth, have conducted a pioneering study exploring the use of smartphone facial scans and AI to analyze facial structures linked to sleep disorders.
–…
Continue Reading
News
Microsoft enhances Microsoft 365 Copilot with task automation, new agents for Teams meetings and employee self-service, and a Copilot Control System for IT management.
Samsung rolls out One UI 6 Watch features to older…
Continue Reading
You’ve heard the saying before, time and time again: sleep occupies nearly a third of our lives. From memory formation, concentration to overall wellness, the power of how we spend that 30 percent of…
Continue Reading
What You Should Know:
– Withings, a global leader in connected health, has announced that its Sleep Rx sleep apnea device has received clearance from the U.S. Food and Drug Administration (FDA).
– Sleep Rx represents…
Continue Reading
Apnea and hypopnea are common sleep disorders characterized by the obstruction of the airways. Polysomnography (PSG) is a sleep study typically used to compute the Apnea-Hypopnea Index (AHI), the number of times a person…
Continue Reading
The demand for home sleep apnea testing (HSAT) devices is escalating, particularly in the context of the coronavirus 2019 (COVID-19) pandemic. The absence of standardized development and verification procedures poses a significant challenge. This…
Continue Reading
What You Should Know:
– Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during…
Continue Reading
